VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH AL 2020 | Molecular diagnosis and MRD monitoring in AML

Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, gives an update on the role of molecular diagnosis and measurable residual disease (MRD) monitoring in acute myeloid leukemia (AML). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter